Pathway Financial Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
41,612
+1,733
| +4% | +$42K | 0.33% | 95 |
|
|
2025
Q1 | $1.01M | Buy |
39,879
+1,034
| +3% | +$26.2K | 0.35% | 89 |
|
|
2024
Q4 | $1.03M | Sell |
38,845
-760
| -2% | -$20.2K | 0.35% | 90 |
|
|
2024
Q3 | $1.15M | Sell |
39,605
-17,982
| -31% | -$520K | 0.52% | 60 |
|
|
2024
Q2 | $1.61M | Sell |
57,587
-1,091
| -2% | -$30.5K | 0.58% | 63 |
|
|
2024
Q1 | $1.63M | Buy |
58,678
+6,823
| +13% | +$189K | 0.59% | 61 |
|
|
2023
Q4 | $1.49M | Sell |
51,855
-3,302
| -6% | -$95.1K | 0.57% | 61 |
|
|
2023
Q3 | $1.83M | Buy |
+55,157
| New | +$1.83M | 0.76% | 46 |
|
|
2023
Q1 | $2.24M | Sell |
54,798
-2,354
| -4% | -$96K | 0.9% | 35 |
|
|
2022
Q4 | $2.93M | Buy |
+57,152
| New | +$2.93M | 1.19% | 24 |
|